上海复旦张江生物医药股份有限公司（复旦张江，股票代码：01349）于2026年6月3日公布截至2026年5月31日的证券变动月报表。公告显示，公司在5月期间未发生新的股份发行、购回、注销或库藏股变动。
\n\n 根据月报，截至本月末，公司H股累计已发行股份为326,000,000股，面值每股人民币0.1元，注册股本合计人民币32,600,000元；A股累计已发行股份为710,572,100股，面值每股人民币0.1元，注册股本合计人民币71,057,210元。整体注册股本总额为人民币103,657,210元，较上月底保持不变。
\n\n 月报同时显示，本期内公司并无涉及股份期权或股权激励计划的变动，亦未出现任何回购或注销股份的情况。公司确认，截至2026年5月底，已符合适用的公众持股量要求。
\n\n 此次月报由公司秘书薛燕签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.